Compare PHAR & FOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PHAR | FOR |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2020 | 2007 |
| Metric | PHAR | FOR |
|---|---|---|
| Price | $17.10 | $28.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $38.00 | $31.75 |
| AVG Volume (30 Days) | 32.4K | ★ 157.2K |
| Earning Date | 01-01-0001 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | ★ $1,662,400,000.00 |
| Revenue This Year | $27.75 | $0.52 |
| Revenue Next Year | $9.39 | $7.72 |
| P/E Ratio | $3,041.22 | ★ $94.13 |
| Revenue Growth | N/A | ★ 10.14 |
| 52 Week Low | $7.50 | $18.00 |
| 52 Week High | $21.34 | $30.74 |
| Indicator | PHAR | FOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 47.52 |
| Support Level | $16.35 | $24.23 |
| Resistance Level | $17.08 | $28.91 |
| Average True Range (ATR) | 0.57 | 0.83 |
| MACD | 0.06 | -0.17 |
| Stochastic Oscillator | 77.74 | 9.90 |
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.